Steven Romano
Vermögen: 23 387 $ am 30.11.2025
Vermögen: 23 387 $ am 30.11.2025
Steven Joseph Romano is currently Chairman at National Pharmaceutical Council since 2021, Director at Evolution Research Group LLC, Independent Director at Dianthus Therapeutics, Inc. since 2024, and Chief Research & Development, Executive VP at Silence Therapeutics Plc since 2019.
Former roles include Senior VP & Head-Global Medicines Development at Pfizer Inc. from 1999 to 2015, Chief Scientific Officer & Executive VP at Keenova Therapeutics Plc from 2015 to 2022, Chief Scientific Officer & Executive VP at Mallinckrodt Pharmaceuticals Ltd. from 2015 to 2022, and President of the International Society For CNS Clinical Trials & Methodology.
Education includes undergraduate studies at Washington University in St. Louis and a doctorate from the University of Missouri School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 12’993 ( 0.01% ) | 23 387 $ | 30.11.2025 | |
| 21.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2023 |
| DIANTHUS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.09.2024 |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Vorsitzender | 04.11.2021 |
Evolution Research Group LLC
Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| MALLINCKRODT PLC | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2022 |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2022 |
| PFIZER INC. | Corporate Officer/Principal | 01.05.2015 |
International Society For Cns Clinical Trials & Methodology | Präsident | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keenova Therapeutics Plc
Keenova Therapeutics Plc Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
University of Missouri School of Medicine
University of Missouri School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolution Research Group LLC
Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
International Society For Cns Clinical Trials & Methodology | |
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen